COVID-19 PCR Testing Program

The AccessDx COVID-19 diagnostic test quickly identifies pathogens including SARS­CoV-2 (COVID-19) so effective actions can begin sooner. AccessDx offers a high-quality clinical-grade RT-PCR test that has been made available pursuant to the FDA's Emergency Use Authorization (EUA) for diagnostic testing in CLIA-certified laboratories.

With a national service footprint, AccessDx is a CLIA (#45D2034771), CAP-accredited, and New York State certified diagnostic laboratory with extensive experience in genetic testing, PCR, toxicology, and pathogen detection.

Get in Touch

AccessDx COVID-19
 Testing Fast Facts

  • Methodology: Advanced RT-PCR
  • Equipment: Applied Biosystems/ ThermoFisher Scientific
  • Collection Process: Nasal (NP) or Oral (OP) swab, provided by AccessDx
  • Turnaround Time: 24-48 business hours from lab receipt
  • Lab Throughput: 10,000 samples/day (potential)
  • Reimbursement: Yes - varies with product
  • Telemedicine Options: Yes via 3rd party provider- varies with product and ordering remains at provider discretion
  • Kit Shipping: Bulk shipments (quantities of 25), returned via individual mailers or via bulk collection based on client operations
  • Cold Chain: Not required for overnight samples, discuss operations with AccessDx client team.

Customized Clinical and Telemedicine Workflows Available

We are ready to help serve the needs of your group. In addition to standard lab data integrations, we are providing a full telemedicine option that can evaluate symptomatic employees and facilitate rapid diagnostic testing as necessary.

How it Works

1. Client Setup

We make sure that every client who is on boarded has their needs met by our services.

2. Assessment  

Member sees provider or completes online assessment

3. Telemedicine Review

Provider reviews assessment( if qualified completes encounter)

4. Test Administration

(Centralized kit availability or direct ship)

COVID-19 + RPP: Get the Complete Picture

In addition to a standalone COVID-19 panel, AccessDx offers a COVID-19+RPP panel that also quickly identifies the presence of over 28 additional pathogens to help aid in clinical decision-making.


  • SARS-CoV-2 (COVID-19)
  • Adenovirus
  • Human Bocavirus
  • Human Coronavirus 229E, HKU1, NL63, 0C43
  • Human Enterovirus D68, (panassay)
  • Human Metapneumovirus(hMPV)
  •  Human Parainfluenza virus 1,2,3,4
  • Human RespiratorySyncytial Virus A (RSVA)
  • Human RespiratorySyncytial Virus B (RSVB)
  • Human Rhinovirus 1/2, 2/2 Human herpesvirus 3 (HHV3 — Varicella Zoster Virus)
  • Human herpesvirus4 (HHV4 -Epstein- BarrVirus)
  • Human herpesvirus 5 (HHV5 - Cytomegalo virus)
  • Human herpesvi rus 6 (HHV6)
  • Influenza A
  • Influenza A/H1-2009
  • Influenza A/H3
  • Influenza B


  • Bordetella bronchiseptica/parapertussis/ pertussis
  • Bordetella pertussis
  • Chlamydophila pneumoniae
  • Haemophilus influenzae
  • Klebsiella pneumoniae
  • Legionella pneumophila
  • Mycoplasma pneumoniae
  • Staphylococcus aureus
  • Streptococcus pneumoniae

Interested in Implementing Testing into Your Programs?
Get in Touch Today

Our plans provides discounts at certain providers for healthcare, wellness, and lifestyle services. Members must pay for all services at the time of service, but will receive a reduced price from those providers who have contracted with the program operator. Providers may not be available in all locations. Offers are subject to change without notice.